These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Combined use of Orgaran and Reopro during coronary angioplasty in patients unable to receive heparin.
    Author: Cantor WJ, Leblanc K, Garvey B, Watson KR, Rasymas A, Strauss BH.
    Journal: Catheter Cardiovasc Interv; 1999 Mar; 46(3):352-5. PubMed ID: 10348139.
    Abstract:
    Orgaran, a heparinoid, has been used successfully in patients with heparin-induced thrombocytopenia. We report three cases in which Orgaran was combined with the glycoprotein IIbIIa receptor antagonist Reopro during coronary angioplasty. Orgaran was given as a single intravenous bolus of 1500 anti-factor Xa units. No ischemic or hemorrhagic complications occurred during or following the procedure.
    [Abstract] [Full Text] [Related] [New Search]